| Code | 5298D | ||||||||||
| MA number | 59/0210/00-S | ||||||||||
| Product Form: | sus inj 1x0,5 ml/25 U (striek.inj.napl.bez ihly) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Merck Sharp & Dohme B.V., Netherland | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Intramuscular use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 07.06.2000 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Vaqta 25 U_06.2019.doc
|
| SPC: |
SPC_VAQTA 25 U_07.2022.pdf
|
| Safety feature | Yes |
| Data update: | 31.07.2020 |
